Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pootrakul

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|January 1, 1985
Thalassemia in southeast Asia: determination of different degrees of severity of anemia in thalassemiaP Wasi, P Pootrakul, S Fucharoen, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Thalassemia in ThailandP Wasi, S Pootrakul, P Pootrakul, et al.
Birth Defects Original Article Series|January 1, 1987
Clinical and hematologic manifestations of AE Bart diseaseS Fucharoen, P Winichagoon, W Prayoonwiwat, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|May 1, 1987
Oxidative stress and antioxidants in beta-thalassaemia/haemoglobin ES Ong-Ajyooth, K Suthipark, D Shumnumsirivath, et al.
Birth Defects Original Article Series|January 1, 1988
Iron metabolism in thalassemiaP Pootrakul, H A Huebers, C A Finch, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunateW Ittarat, S Looareesuwan, P Pootrakul, et al.
Biochimica Et Biophysica Acta|June 26, 1998
The form of iron oxide deposits in thalassemic tissues varies between different groups of patients: a comparison between Thai beta-thalassemia/hemoglobin E patients and Australian beta-thalassemia patientsT G St Pierre, W Chua-anusorn, J Webb, et al.
Lancet (London, England)|September 16, 1978
A syndrome of hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusionsP Wasi, S Na-Nakorn, P Pootrakul, et al.
Blood|January 1, 1987
Erythroid marrow function in anemic patientsM Cazzola, P Pootrakul, H A Huebers, et al.
Blood|February 7, 2001
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapyW Breuer, M J Ermers, P Pootrakul, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|January 1, 1985
Thalassemia in southeast Asia: determination of different degrees of severity of anemia in thalassemiaP Wasi, P Pootrakul, S Fucharoen, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Thalassemia in ThailandP Wasi, S Pootrakul, P Pootrakul, et al.
Birth Defects Original Article Series|January 1, 1987
Clinical and hematologic manifestations of AE Bart diseaseS Fucharoen, P Winichagoon, W Prayoonwiwat, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|May 1, 1987
Oxidative stress and antioxidants in beta-thalassaemia/haemoglobin ES Ong-Ajyooth, K Suthipark, D Shumnumsirivath, et al.
Birth Defects Original Article Series|January 1, 1988
Iron metabolism in thalassemiaP Pootrakul, H A Huebers, C A Finch, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunateW Ittarat, S Looareesuwan, P Pootrakul, et al.
Biochimica Et Biophysica Acta|June 26, 1998
The form of iron oxide deposits in thalassemic tissues varies between different groups of patients: a comparison between Thai beta-thalassemia/hemoglobin E patients and Australian beta-thalassemia patientsT G St Pierre, W Chua-anusorn, J Webb, et al.
Lancet (London, England)|September 16, 1978
A syndrome of hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusionsP Wasi, S Na-Nakorn, P Pootrakul, et al.
Blood|January 1, 1987
Erythroid marrow function in anemic patientsM Cazzola, P Pootrakul, H A Huebers, et al.
Blood|February 7, 2001
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapyW Breuer, M J Ermers, P Pootrakul, et al.
Pageof 6